Our Newsletter

IRAP, A novel biomarker of prediabetes and Type 2 diabetes?

Our Newsletter

Type 2 diabetes is increasing worldwide, causing both a health and socioeconomic burden. Fortunately, type 2 diabetes can be prevented if proper intervention is introduced during the early stages of

Meet The Scientist – Sumi John

Our Newsletter

SUMI ELSA JOHN Meet the scientists behind DDI’s research SUMI ELSA JOHN is graduated with a master’s degree in Bioinformatics and Computational Biology from the University of Leeds, UK. Her

Meet The Scientist – Arshad Channanath

Our Newsletter

ARSHAD MOHAMMAD CHANNANATH Meet the scientists behind DDI’s research ARSHAD MOHAMMAD CHANNANATH is a software engineer with a master’s degree in bioinformatics. His expertise includes anal

Obesity and Mitochondria – Research during 2020 in a glance

Our Newsletter

Do you inherit your obesity from your mom? Maternally inherited mitochondrial DNA (mtDNA) is used to trace the kinship through the female line, it accumulates mutations over several generations. C

Heritability and Metabolic Traits – Research during 2020 in a glance

Our Newsletter

Number, Impact factor, and citations of DDI’s published articles have increased significantly during 2020 as compared to previous years. Here we highlight some of the published work in the dep

DDI released a new tool PHARMAKU

Our Newsletter

Tailoring treatments for each patient with precision medicine. Modern medications save millions a year; however, most available drugs are “one size fits all” and fail to work similarly for everyon

Meet the Scientist – Dr. Anwar Mohammad

Our Newsletter

DR. ANWAR MOHAMMAD Meet the scientists behind DDI’s research Dr. Anwar joined DDI in 2012 as a scientist in the Department of Public Health. Since 2018, he has been working within the Bioch

COVID19: N720D AN ACE2 VARIANT WITH HIGHER AFFINITY TO TMPRSS2

Our Newsletter

The rate of infection and mortality of SARS-CoV-2 varies based on the geographical spread of the virus as a consequence of several factors such as isolation, quarantine, differences in the genetic ma

DDI joins COVIDIAB, an international group of researchers that aim to investigate newly diagnosed COVID-19-related diabetes.

Our Newsletter

Recent evidence emerges showing that COVID-19 may cause diabetes in patients with no previous history of diabetes. It has been well-established in the early months of the COVID-19 pandemic that ob

DR. SARDAR SINDHU

Our Newsletter

Dr. Sardar joined DDI in 2014 and has been serving as Scientist II and Manager of the Animal and Imaging Core Facility since 2016. He received his Ph.D. in Immunology and Virology from the Univer

Markers for Inflammation in Obesity and Diabetes

Our Newsletter

DDI finds potentially critical biomarker of metabolic inflammation in obesity and diabetes Obesity, an important risk factor in the development of diabetes, is often associated with chronic infl

DDI Researchers Volunteer at Local Hospitals to Help with SARS-COV-2 Testing

Our Newsletter

Researchers at DDI have volunteered their time and expertise to help screen patients for COVID-19 A group of DDI researchers offered to volunteer their skills at different local hospitals to hel

COVID-19: DDI Find Possible Link Between Genetics and Disease Severity

Our Newsletter

Naturally occurring genetic variations in human populations may be the key to the differences in susceptibility to COVID-19 and the severity of its symptoms around the world. ACE2 and FURIN are im

Dr. Muthukrishnan Eaaswarkhanth

Our Newsletter

Eaaswarkhanth joined DDI in March 2016, having previously worked at the State University of New York at Buffalo as well as New York State Department of Health, USA. He has a PhD in Molecular Populati

Metabolic disorders In kuwait – are our Ancestral genes to Blame?

Our Newsletter

Why is the prevalence of obesity and metabolic disorders so high in the Middle East? Are diet and lifestyle choices the sole culprits? A new study1 conducted at Dasman Diabetes Institute may have fou

SARS-CoV-2: Researchers at DDI do their part

Our Newsletter

Amid the SARS-CoV-2 pandemic, researchers at DDI, led by Chief Scientific Officer Prof. Fahd Al-Mulla, are collaborating with the MoH to help contain the spread and mitigate risks for the population.

Novel Non-invasive Method To Detect Vascular Complications In Patients With Type 2 Diabetes

Our Newsletter

Complications of diabetes can be an emotional topic for those with diabetes. The high sugar level in the blood can damage tissues throughout the body, such as nerves, eyes, or kidneys. These side eff

FATEMA AL-RASHED, PH.D, Post-doc Researcher Immunology & Microbiology Department

Our Newsletter

Fatema Al-Rashed, Ph.D. is a post-doc researcher at the Immunology & Microbiology Department of Dasman Diabetes Institute in Kuwait, since 2016. From 2012 to 2015, she worked as a researcher at F

Immunometabolism – A Promising Route For Drug Development

Our Newsletter

Immunometabolism has emerged recently as a very exciting field of research in immunology that investigates the interplay between immunological and metabolic processes. Interest in this field is gaini

In-situ Protein Detection “the Power Of In-cell Western Blotting”

Our Newsletter

Western blot is a powerful technique originated in the laboratory of Harry Towbin at the Friedrich Miescher Institute in Basel, Switzerland in 1979. This sensitive immunological method identifies pro

Would you like to subscribe
to our newsletter?